Cogent Biosciences Inc (COGT) Analysis & Forecast for 2024

Cogent Biosciences Inc (NASDAQ: COGT) is -1.53% lower on its value in year-to-date trading and has touched a low of $3.67 and a high of $14.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The COGT stock was last observed hovering at around $5.88 in the last trading session, with the day’s loss setting it -0.09%.

Currently trading at $5.79, the stock is 16.92% and 2.79% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.01 million and changing -1.53% at the moment leaves the stock -39.47% off its SMA200. COGT registered -60.04% loss for a year compared to 6-month loss of -51.75%. The firm has a 200-day simple moving average (SMA200) of -$2.62.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a 8.43% gain in the last 1 month and extending the period to 3 months gives it a -19.30%, and is 1.58% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.97% over the week and 9.08% over the month.

Distance from 52-week low is 57.77% and -60.07% from its 52-week high. The company has generated returns on investments over the last 12 months (-55.39%).

Cogent Biosciences Inc quarterly earnings per share for the current quarter are estimated at -$0.55.The EPS is expected to grow by 3.29% this year.

Cogent Biosciences Inc (COGT) Top Institutional Holders

200 institutions hold shares in Cogent Biosciences Inc (COGT), with institutional investors hold 112.49% of the company’s shares. The shares outstanding are 69.89M, and float is at 69.15M with Short Float at 7.29%. Institutions hold 112.31% of the Float.

The top institutional shareholder in the company is RA Capital Management, L.P. with over 6.42 million shares valued at $75.97 million. The investor’s holdings represent 7.51% of the COGT Shares outstanding. As of Jun 29, 2023, the second largest holder is Tcg Crossover Management, Llc with 5.63 million shares valued at $66.67 million to account for 6.59% of the shares outstanding. The other top investors are Commodore Capital Lp which holds 5.57 million shares representing 6.51% and valued at over $65.9 million, while Blackrock Inc. holds 6.41% of the shares totaling 5.48 million with a market value of $64.86 million.

Cogent Biosciences Inc (COGT) Insider Activity

A total of 0 insider transactions have happened at Cogent Biosciences Inc (COGT) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by Fairmount Funds Management LLC,the company’s10% Owner. SEC filings show that Fairmount Funds Management LLC bought 800,000 shares of the company’s common stock on Jun 09 at a price of $12.00 per share for a total of $9.6 million. Following the purchase, the insider now owns 3.27 million shares.